序曲 发表于 2025-3-28 17:58:10

http://reply.papertrans.cn/11/1008/100758/100758_41.png

有毛就脱毛 发表于 2025-3-28 22:27:06

http://reply.papertrans.cn/11/1008/100758/100758_42.png

压碎 发表于 2025-3-29 01:12:45

http://reply.papertrans.cn/11/1008/100758/100758_43.png

Canary 发表于 2025-3-29 04:09:30

http://reply.papertrans.cn/11/1008/100758/100758_44.png

殖民地 发表于 2025-3-29 08:42:50

João Aranda Brandão,Sofia Leal Rodriguess is one path to address quality issues in patient-specific design. We present in this chapter an example of a design control approach for quality control of 3D patient-specific devices using a recently developed airway splint as a paradigmatic example for small lot 3D printed patient-specific devices.

不可知论 发表于 2025-3-29 13:45:49

Advances in Ergonomics in Designl limitations, such as inadequate control and resolution cell deposition, to create a complex tissue micro-microenvironment, shear stress-induced cell damage, and constraints associated with the current bioink materials.

气候 发表于 2025-3-29 18:12:55

Francisco Rebelo,Marcelo Soaresration were also used to direct cell fates. Since the diversity of bioink and the capability of fabricating complex structures, inkjet bioprinting behaves as an effective tool in the field of biofabrication. The applications of inkjet printing include but not limit to drug formulation, tissue repair, and cancer research.

Lipoprotein(A) 发表于 2025-3-29 21:21:00

Effect of Driving Context on Design Dialogue is described in detail in this chapter which includes rheology, printability, cross-linking, long-term stability in medium, cell viability, and stimulation of cells during tissue growth. The commercialization process of bioinks is also described.

反叛者 发表于 2025-3-30 00:15:32

http://reply.papertrans.cn/11/1008/100758/100758_49.png

Myosin 发表于 2025-3-30 06:16:23

http://reply.papertrans.cn/11/1008/100758/100758_50.png
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: 3D Printing and Biofabrication; Aleksandr Ovsianikov,James Yoo,Vladimir Mironov Reference work 2018 Springer International Publishing AG,